Analgesics
Antiandrogens
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lactoferrin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Peg.. Lambda
Quercetin
Remdesivir
Vitamins

Other
Feedback
Home
Top
Results
All N‑acetylcysteine studies
Meta analysis
 
Feedback
Home
c19early.org COVID-19 treatment researchN-acetylcysteineN-acetylcys.. (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   All Outcomes   Recent:  
0 0.5 1 1.5 2+ Mortality 93% Improvement Relative Risk Hospitalization 78% Recovery time 16% N-acetylcysteine  Ghayour et al.  EARLY TREATMENT  RCT Is early treatment with N-acetylcysteine beneficial for COVID-19? RCT 150 patients in Iran (April - September 2022) Lower mortality (p=0.013) and hospitalization (p<0.0001) c19early.org Ghayour et al., Research Square, January 2023 Favors N-acetylcysteine Favors control

Evaluation of the recovery rate and prevention of hospitalization among covid-19 outpatients: a randomized clinical trial comparing N-acetylcysteine with Bromhexine

Ghayour et al., Research Square, doi:10.21203/rs.3.rs-2309373/v2, IRCT20220302054167N1
Jan 2023  
  Twitter
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
RCT 225 outpatients in Iran showing lower mortality and hospitalization, and faster recovery with N-acetylcysteine and bromhexine. Baseline information per group is not provided, Figure 1 has the control group hospitalization status switched and the totals do not match, and the registration and previous version of this paper do not include the control group. N-acetylcysteine 600mg daily for 5 days, bromhexine 8mg tid for 5 days. This study is excluded in meta analysis: inconsistent data, no baseline group details, control group not in previous version.
This study includes N-acetylcysteine and bromhexine.
risk of death, 93.3% lower, RR 0.07, p = 0.01, treatment 0 of 75 (0.0%), control 7 of 75 (9.3%), NNT 11, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm).
risk of hospitalization, 78.0% lower, RR 0.22, p < 0.001, treatment 11 of 75 (14.7%), control 50 of 75 (66.7%), NNT 1.9.
recovery time, 15.9% lower, relative time 0.84, p = 0.02, treatment mean 12.65 (±0.9) n=75, control mean 15.04 (±8.557) n=75.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ghayour et al., 3 Jan 2023, Randomized Controlled Trial, Iran, preprint, mean age 58.6, 4 authors, study period April 2022 - September 2022, trial IRCT20220302054167N1.
Contact: anahitaeslami1995@gmail.com.
All Studies   All Outcomes   Submit Updates or Corrections
This PaperN-acetylcys..All
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit